MarketBeat Daily Ratings for Thursday, November 21, 2024
Ratings changes for MicroStrategy, NVIDIA, NVIDIA, Palo Alto Networks, NVIDIA, CrowdStrike, Palo Alto Networks and more...Text "MarketBeat" to 68285 to get SMS breaking news alerts for stocks on your watchlist and other special reports. Learn More.November 21st, 2024 Today's Top Stories | | By Thomas Hughes | November 21, 2024 07:33 AM |
| | | By The Associated Press | November 21, 2024 07:38 AM |
| | By Thomas Hughes | November 21, 2024 09:31 AM |
| | | By The Associated Press | November 21, 2024 02:08 AM |
| | By Gabriel Osorio-Mazilli | November 21, 2024 08:05 AM |
|
|
Analysts' Upgrades | | AngloGold Ashanti (NYSE:AU) was upgraded by analysts at Scotiabank from a "sector underperform" rating to a "sector perform" rating.The current price is $24.68. | | Bank of Nova Scotia (NYSE:BNS) (TSE:BNS) was upgraded by analysts at Barclays PLC from an "underweight" rating to an "equal weight" rating.The current price is $56.53. | | Compañía de Minas Buenaventura S.A.A. (NYSE:BVN) was upgraded by analysts at Scotiabank from a "sector underperform" rating to a "sector perform" rating.The current price is $12.30. | | DT Midstream (NYSE:DTM) was upgraded by analysts at Citigroup Inc. from a "neutral" rating to a "buy" rating. They now have a $115.00 price target on the stock, up previously from $90.00. This represents a 7.0% upside from the current price of $107.50. | | EVERTEC (NYSE:EVTC) was upgraded by analysts at Morgan Stanley from an "underweight" rating to an "equal weight" rating. They now have a $35.00 price target on the stock, up previously from $33.00. This represents a 3.3% downside from the current price of $36.19. | | ON (NYSE:ONON) was upgraded by analysts at Raymond James from an "outperform" rating to a "strong-buy" rating. They now have a $63.00 price target on the stock, up previously from $58.00. This represents a 14.1% upside from the current price of $55.23. | | Palo Alto Networks (NASDAQ:PANW) was upgraded by analysts at Rosenblatt Securities from a "neutral" rating to a "buy" rating. They now have a $430.00 price target on the stock, up previously from $390.00. This represents a 9.0% upside from the current price of $394.46. | | Pebblebrook Hotel Trust (NYSE:PEB) was upgraded by analysts at Compass Point from a "neutral" rating to a "buy" rating. They now have a $17.00 price target on the stock. This represents a 33.0% upside from the current price of $12.78. | | Piedmont Lithium (NASDAQ:PLL) was upgraded by analysts at Macquarie from an "underperform" rating to a "neutral" rating. They now have a $13.50 price target on the stock. This represents a 10.2% upside from the current price of $12.25. | | Royal Bank of Canada (NYSE:RY) (TSE:RY) was upgraded by analysts at Barclays PLC from an "equal weight" rating to an "overweight" rating.The current price is $124.30. | | Sage Therapeutics (NASDAQ:SAGE) was upgraded by analysts at Royal Bank of Canada from an "underperform" rating to a "sector perform" rating. They now have a $4.00 price target on the stock. This represents a 19.8% downside from the current price of $4.99. | | Star Bulk Carriers (NASDAQ:SBLK) was upgraded by analysts at DNB Markets from a "sell" rating to a "hold" rating. They now have a $20.20 price target on the stock, up previously from $19.30. This represents a 8.0% upside from the current price of $18.70. |
|
View More Upgrades
|
Analysts' Downgrades | | Adient (NYSE:ADNT) was downgraded by analysts at Bank of America Co. from a "buy" rating to a "neutral" rating. They now have a $24.00 price target on the stock, down previously from $30.00. This represents a 27.7% upside from the current price of $18.80. | | Grab (NASDAQ:GRAB) was downgraded by analysts at China Renaissance from a "buy" rating to a "hold" rating. They now have a $5.40 price target on the stock. This represents a 3.9% downside from the current price of $5.62. | | MARA (NASDAQ:MARA) was downgraded by analysts at Compass Point from a "buy" rating to a "neutral" rating. They now have a $25.00 price target on the stock, up previously from $21.00. This represents a 7.5% upside from the current price of $23.25. | | Pyxis Oncology (NASDAQ:PYXS) was downgraded by analysts at William Blair from an "outperform" rating to a "market perform" rating.The current price is $2.06. | | RBC Bearings (NYSE:RBC) was downgraded by analysts at Bank of America Co. from a "buy" rating to a "neutral" rating. They now have a $335.00 price target on the stock, up previously from $330.00. This represents a 3.9% upside from the current price of $322.41. | | Shopify (NYSE:SHOP) (TSE:SHOP) was downgraded by analysts at DZ Bank AG from a "hold" rating to a "sell" rating.The current price is $106.83. | | Seven & i (OTC:SVNDF) was downgraded by analysts at JPMorgan Chase & Co. from an "overweight" rating to a "neutral" rating. | | Toronto-Dominion Bank (NYSE:TD) (TSE:TD) was downgraded by analysts at Barclays PLC from an "equal weight" rating to an "underweight" rating.The current price is $55.64. | | The Hanover Insurance Group (NYSE:THG) was downgraded by analysts at Janney Montgomery Scott from a "buy" rating to a "neutral" rating. They now have a $176.00 price target on the stock. This represents a 8.1% upside from the current price of $162.76. | | Travelers Companies (NYSE:TRV) was downgraded by analysts at Janney Montgomery Scott from a "buy" rating to a "neutral" rating. They now have a $280.00 price target on the stock. This represents a 8.0% upside from the current price of $259.24. | | Ulta Beauty (NASDAQ:ULTA) was downgraded by analysts at William Blair from an "outperform" rating to a "market perform" rating.The current price is $334.02. | | Walmart (NYSE:WMT) was downgraded by analysts at DZ Bank AG from a "buy" rating to a "hold" rating. They now have a $91.00 price target on the stock. This represents a 3.4% upside from the current price of $88.01. | | XPeng (NYSE:XPEV) was downgraded by analysts at The Goldman Sachs Group, Inc. from a "buy" rating to a "neutral" rating. They now have a $12.50 price target on the stock. This represents a 3.0% upside from the current price of $12.14. |
|
View More Downgrades
|
Analysts' New Coverage | | Amentum (NYSE:AMTM) is now covered by analysts at Raymond James. They set an "outperform" rating and a $30.00 price target on the stock. This represents a 22.9% upside from the current price of $24.41. | | Apellis Pharmaceuticals (NASDAQ:APLS) is now covered by analysts at Morgan Stanley. They set an "equal weight" rating and a $31.00 price target on the stock. This represents a 15.9% upside from the current price of $26.74. | | Broadridge Financial Solutions (NYSE:BR) is now covered by analysts at UBS Group AG. They set a "neutral" rating and a $250.00 price target on the stock. This represents a 9.8% upside from the current price of $227.76. | | The Ensign Group (NASDAQ:ENSG) is now covered by analysts at UBS Group AG. They set a "buy" rating and a $175.00 price target on the stock. This represents a 20.3% upside from the current price of $145.47. | | 4D Molecular Therapeutics (NASDAQ:FDMT) is now covered by analysts at Morgan Stanley. They set an "underweight" rating and a $8.00 price target on the stock. This represents a 0.7% downside from the current price of $8.06. | | GE Vernova (NYSE:GEV) is now covered by analysts at Wells Fargo & Company. They set an "overweight" rating and a $385.00 price target on the stock. This represents a 9.0% upside from the current price of $353.16. | | International General Insurance (NASDAQ:IGIC) is now covered by analysts at Oppenheimer Holdings Inc.. They set an "outperform" rating and a $30.00 price target on the stock. This represents a 17.6% upside from the current price of $25.50. | | Mativ (NYSE:MATV) is now covered by analysts at Stifel Nicolaus. They set a "hold" rating and a $15.50 price target on the stock. This represents a 22.2% upside from the current price of $12.68. | | Merus (NASDAQ:MRUS) is now covered by analysts at The Goldman Sachs Group, Inc.. They set a "buy" rating and a $73.00 price target on the stock. This represents a 66.6% upside from the current price of $43.83. | | Medicis Pharmaceutical (NYSE:MRX) is now covered by analysts at HSBC Holdings plc. They set a "buy" rating and a $33.00 price target on the stock. This represents a 14.1% upside from the current price of $28.91. | | Northeast Bank (NASDAQ:NBN) is now covered by analysts at Keefe, Bruyette & Woods. They set a "market perform" rating and a $102.00 price target on the stock. This represents a 5.0% upside from the current price of $97.18. | | Stardust Power (NASDAQ:SDST) is now covered by analysts at Roth Mkm. They set a "buy" rating and a $13.00 price target on the stock. This represents a 82.3% upside from the current price of $7.13. | | Sunrise Communications (NASDAQ:SNRE) is now covered by analysts at Deutsche Bank Aktiengesellschaft. They set a "buy" rating on the stock.The current price is $47.00. | | UMB Financial (NASDAQ:UMBF) is now covered by analysts at Morgan Stanley. They set an "overweight" rating and a $156.00 price target on the stock. This represents a 27.2% upside from the current price of $122.66. | | Vera Therapeutics (NASDAQ:VERA) is now covered by analysts at Wells Fargo & Company. They set an "overweight" rating and a $70.00 price target on the stock. This represents a 48.5% upside from the current price of $47.13. |
|
View More New Coverage
|
Calendars from MarketBeat | |
|
| Get 30 Days of MarketBeat All Access Free | | Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: | Best-in-Class Portfolio MonitoringView the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.Stock Ideas and RecommendationsGet daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.Advanced Stock Screeners and Research ToolsIdentify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. | | Start Your 30-Day Free Trial |
| Upgrade Your Subscription | | Upgrade to MarketBeat All Access and receive your premium edition of MarketBeat Daily at 9:00 AM ET. | | Upgrade Now |
|
| Manage Your Watchlist | | View and add up to five holdings to your watchlist. | | View My Portfolio |
|
| Join Our Facebook Group | | Join MarketBeat’s free stock discussion and trading idea group on Facebook. | | Join Now |
|
Thank you for subscribing to MarketBeat!We empower individual investors to make better trading decisions by providing real-time financial information and objective market research. MarketBeat is a small business and email is a crucial tool for us to share information, news, trading ideas and financial products and services with our subscribers (that's you!). If you have questions about your subscription, feel free to contact our U.S. based support team via email at contact@marketbeat.com.
If you would like to unsubscribe or change which emails you receive, you can manage your mailing preferences or unsubscribe from these emails.
© 2006-2024 MarketBeat Media, LLC.
345 N Reid Place, Suite 620, Sioux Falls, SD 57103. United States. Today's Bonus Content: AI Cornerstone |
